| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 476 |
| 1 | SILDENAFIL CITRATE | 389 |
| 2 | MACITENTAN | 336 |
| 3 | TADALAFIL | 297 |
| 4 | AMBRISENTAN | 292 |
| 5 | SILDENAFIL | 257 |
| 6 | FUROSEMIDE | 249 |
| 7 | SELEXIPAG | 195 |
| 8 | BOSENTAN | 193 |
| 9 | RIOCIGUAT | 179 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 102 | 0.0078 |
| 1 | SELEXIPAG | 195 | 0.0075 |
| 2 | NITRIC OXIDE | 28 | 0.0061 |
| 3 | RIOCIGUAT | 179 | 0.0054 |
| 4 | SILDENAFIL POWDER, | 173 | 0.0048 |
| 5 | MACITENTAN | 336 | 0.0048 |
| 6 | BOSENTAN | 193 | 0.0038 |
| 7 | TREPROSTINIL | 476 | 0.0037 |
| 8 | SILDENAFIL CITRATE | 389 | 0.0030 |
| 9 | TADALAFIL | 297 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 613 |
| 1 | Prostacycline Vasodilator [EPC] | 553 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 446 |
| 3 | Loop Diuretic [EPC] | 297 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 195 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 179 |
| 6 | Aldosterone Antagonist [EPC] | 158 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 147 |
| 8 | Corticosteroid [EPC] | 133 |
| 9 | Factor Xa Inhibitor [EPC] | 113 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 195 | 0.0075 |
| 1 | Prostacycline [EPC] | 6 | 0.0064 |
| 2 | Soluble Guanylate Cyclase Stimulator [EPC] | 179 | 0.0053 |
| 3 | Prostacycline Vasodilator [EPC] | 553 | 0.0040 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 446 | 0.0033 |
| 5 | Endothelin Receptor Antagonist [EPC] | 613 | 0.0031 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 7 | Provitamin D2 Compound [EPC] | 68 | 0.0023 |
| 8 | Oxytocic [EPC] | 5 | 0.0016 |
| 9 | alpha-1 Adrenergic Agonist [EPC] | 6 | 0.0014 |